News | October 05, 2008

Syracuse Radiation Oncology Adopts RapidArc

October 6, 2008 - Doctors in Syracuse, NY, have deployed RapidArc radiotherapy technology from Varian Medical Systems.

A new weapon in the fight against cancer, RapidArc delivers a precise image-guided IMRT treatment in two minutes or less, which is two to eight times faster than was previously possible with conventional IMRT, said Varian.

A 70-year-old prostate cancer patient was the first person to begin a course of RapidArc treatments at Syracuse Radiation Oncology, an early adopter and the one of the first sites in upstate New York to offer this form of treatment. Each of his daily treatments is taking just under two minutes to deliver.

“Compared with a traditional IMRT approach, we’re finding that a RapidArc treatment is noticeably faster to deliver,” said Neil Mariados, M.D., radiation oncologist, Syracuse Radiation Oncology. “A shorter treatment time means that patients spend less time holding still, and we believe this has the potential to improve treatment accuracy as the targeted tumor is less likely to shift position during a shorter treatment. Because RapidArc provides the accuracy we demand in a patient's radiotherapy, but in a shorter time frame, we are able to provide exceptional care to each of them.”

For more information: www.varian.com

Related Content

Hypofractionated Radiation Provides Same Prostate Cancer Outcomes as Conventional Radiation
News | Intensity Modulated Radiation Therapy (IMRT) | October 31, 2018
An analysis led by researchers at Philadelphia’s Fox Chase Cancer Center found treating localized prostate cancer with...
IBA Completes Installation of Two Proteus One Proton Therapy Systems in Japan
News | Proton Therapy | July 30, 2018
IBA (Ion Beam Applications S.A.) announced that they completed the first two installations of the Proteus One proton...
​ITN Celebrates World Cancer Day 2018
News | Radiation Oncology | February 01, 2018
World Cancer Day takes place annually on Feb.
UZ Leuven Treats First European Patient on Varian Halcyon Cancer Treatment System
News | Intensity Modulated Radiation Therapy (IMRT) | October 25, 2017
Varian recently announced an 80-year-old male with head and neck cancer became the first patient in Europe to be...
Varian Receives FDA 510k Clearance for Halcyon Treatment System
Technology | Intensity Modulated Radiation Therapy (IMRT) | July 05, 2017
Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Halcyon system,...
First New York Metropolitan Hospital Treats Cancer Patients With Accuray Radixact System
News | Image Guided Radiation Therapy (IGRT) | July 03, 2017
Accuray Inc. and Montefiore Einstein Center for Cancer Care (MECCC), part of the Montefiore Health System (MHS),...
IUCT Oncopole Installs First Radixact Radiotherapy System in France
News | Intensity Modulated Radiation Therapy (IMRT) | June 20, 2017
Accuray Inc. announced that the University Cancer Institute of Toulouse Oncopole (IUCT Oncopole) in Toulouse, France,...
cervical and endometrial cancer, IMRT, intensity modulated radiation therapy, side effects, ASTRO 2016 study
News | Intensity Modulated Radiation Therapy (IMRT) | September 29, 2016
Patients with cervical and endometrial cancer have fewer gastrointestinal and genitourinary side effects and experience...